<?xml version="1.0"?>
<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.4 20190208//EN"
       "JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.4" xml:lang="en">
 <front>
  <journal-meta>
   <journal-id journal-id-type="publisher-id">Russian veterinary journal</journal-id>
   <journal-title-group>
    <journal-title xml:lang="en">Russian veterinary journal</journal-title>
    <trans-title-group xml:lang="ru">
     <trans-title>Российский ветеринарный журнал</trans-title>
    </trans-title-group>
   </journal-title-group>
   <issn publication-format="print">2500-4379</issn>
  </journal-meta>
  <article-meta>
   <article-id pub-id-type="publisher-id">98606</article-id>
   <article-id pub-id-type="doi">10.32416/2500-4379-2025-2-35-44</article-id>
   <article-categories>
    <subj-group subj-group-type="toc-heading" xml:lang="ru">
     <subject>СОВРЕМЕННЫЕ ФАРМАКО- И БИОПРЕПАРАТЫ</subject>
    </subj-group>
    <subj-group subj-group-type="toc-heading" xml:lang="en">
     <subject>MODERN PHARMACOLOGICAL DRUGS &amp; BIOPREPARATIONS</subject>
    </subj-group>
    <subj-group>
     <subject>СОВРЕМЕННЫЕ ФАРМАКО- И БИОПРЕПАРАТЫ</subject>
    </subj-group>
   </article-categories>
   <title-group>
    <article-title xml:lang="en">Pharmacotoxicological evaluation of a new original medicinal product based on gabapentin and succinate trazodone Trazapentine® tablets for cats</article-title>
    <trans-title-group xml:lang="ru">
     <trans-title>Фармако-токсикологическая оценка нового оригинального лекарственного препарата на основе габапентина и сукцината тразодона Тразапентин® таблетки для кошек</trans-title>
    </trans-title-group>
   </title-group>
   <contrib-group content-type="authors">
    <contrib contrib-type="author">
     <name-alternatives>
      <name xml:lang="ru">
       <surname>Кузьминова</surname>
       <given-names>Елена Васильевна</given-names>
      </name>
      <name xml:lang="en">
       <surname>Kuz'minova</surname>
       <given-names>Elena Vasil'evna</given-names>
      </name>
     </name-alternatives>
     <bio xml:lang="ru">
      <p>доктор ветеринарных наук;</p>
     </bio>
     <bio xml:lang="en">
      <p>doctor of veterinary sciences;</p>
     </bio>
     <xref ref-type="aff" rid="aff-1"/>
    </contrib>
    <contrib contrib-type="author">
     <name-alternatives>
      <name xml:lang="ru">
       <surname>Белоглазов</surname>
       <given-names>Денис Валерьевич</given-names>
      </name>
      <name xml:lang="en">
       <surname>Beloglazov</surname>
       <given-names>Denis Valer'evich</given-names>
      </name>
     </name-alternatives>
     <bio xml:lang="ru">
      <p>кандидат биологических наук;</p>
     </bio>
     <bio xml:lang="en">
      <p>candidate of sciences in biology;</p>
     </bio>
     <xref ref-type="aff" rid="aff-2"/>
     <xref ref-type="aff" rid="aff-3"/>
     <xref ref-type="aff" rid="aff-4"/>
    </contrib>
    <contrib contrib-type="author">
     <name-alternatives>
      <name xml:lang="ru">
       <surname>Мукасеев</surname>
       <given-names>Сергей Владимирович</given-names>
      </name>
      <name xml:lang="en">
       <surname>Mukaseev</surname>
       <given-names>Sergey Vladimirovich</given-names>
      </name>
     </name-alternatives>
     <bio xml:lang="ru">
      <p>кандидат ветеринарных наук;</p>
     </bio>
     <bio xml:lang="en">
      <p>candidate of veterinary sciences;</p>
     </bio>
     <xref ref-type="aff" rid="aff-5"/>
     <xref ref-type="aff" rid="aff-6"/>
     <xref ref-type="aff" rid="aff-7"/>
     <xref ref-type="aff" rid="aff-8"/>
    </contrib>
    <contrib contrib-type="author">
     <name-alternatives>
      <name xml:lang="ru">
       <surname>Пархоменко</surname>
       <given-names>Сергей Александрович</given-names>
      </name>
      <name xml:lang="en">
       <surname>Parhomenko</surname>
       <given-names>Sergey Aleksandrovich</given-names>
      </name>
     </name-alternatives>
     <xref ref-type="aff" rid="aff-9"/>
    </contrib>
    <contrib contrib-type="author">
     <name-alternatives>
      <name xml:lang="ru">
       <surname>Зейналов</surname>
       <given-names>Орхан Ахмедович</given-names>
      </name>
      <name xml:lang="en">
       <surname>Zeynalov</surname>
       <given-names>Orhan Ahmedovich</given-names>
      </name>
     </name-alternatives>
     <bio xml:lang="ru">
      <p>кандидат биологических наук;</p>
     </bio>
     <bio xml:lang="en">
      <p>candidate of sciences in biology;</p>
     </bio>
     <xref ref-type="aff" rid="aff-10"/>
     <xref ref-type="aff" rid="aff-11"/>
     <xref ref-type="aff" rid="aff-12"/>
    </contrib>
   </contrib-group>
   <aff-alternatives id="aff-1">
    <aff>
     <institution xml:lang="ru">Краснодарский научный центр по зоотехнии и ветеринарии</institution>
     <city>Краснодар</city>
     <country>Россия</country>
    </aff>
    <aff>
     <institution xml:lang="en">Краснодарский научный центр по зоотехнии и ветеринарии</institution>
     <city>Краснодар</city>
     <country>Russian Federation</country>
    </aff>
   </aff-alternatives>
   <aff-alternatives id="aff-2">
    <aff>
     <institution xml:lang="ru">ООО «НПК «СКиФФ»</institution>
     <city>Москва</city>
     <country>Россия</country>
    </aff>
    <aff>
     <institution xml:lang="en">LLC «NPC «SKiFF»</institution>
     <city>Moscow</city>
     <country>Russian Federation</country>
    </aff>
   </aff-alternatives>
   <aff-alternatives id="aff-3">
    <aff>
     <institution xml:lang="ru">ООО «АГ «Аспект»</institution>
     <city>Москва</city>
     <country>Россия</country>
    </aff>
    <aff>
     <institution xml:lang="en">LLC AG Aspect</institution>
     <city>Moscow</city>
     <country>Russian Federation</country>
    </aff>
   </aff-alternatives>
   <aff-alternatives id="aff-4">
    <aff>
     <institution xml:lang="ru">ООО «НВП «Астрафарм»</institution>
     <city>Москва</city>
     <country>Россия</country>
    </aff>
    <aff>
     <institution xml:lang="en">LLC «RDE «Astrapharm»</institution>
     <city>Moscow</city>
     <country>Russian Federation</country>
    </aff>
   </aff-alternatives>
   <aff-alternatives id="aff-5">
    <aff>
     <institution xml:lang="ru">ООО «НПК «СКиФФ»</institution>
     <city>Москва</city>
     <country>Россия</country>
    </aff>
    <aff>
     <institution xml:lang="en">LLC «NPC «SKiFF»</institution>
     <city>Moscow</city>
     <country>Russian Federation</country>
    </aff>
   </aff-alternatives>
   <aff-alternatives id="aff-6">
    <aff>
     <institution xml:lang="ru">ООО «АГ «Аспект»</institution>
     <city>Москва</city>
     <country>Россия</country>
    </aff>
    <aff>
     <institution xml:lang="en">LLC «AG «Aspect»</institution>
     <city>Moscow</city>
     <country>Russian Federation</country>
    </aff>
   </aff-alternatives>
   <aff-alternatives id="aff-7">
    <aff>
     <institution xml:lang="ru">ООО «НВП «Астрафарм»</institution>
     <city>Москва</city>
     <country>Россия</country>
    </aff>
    <aff>
     <institution xml:lang="en">LLC «RDE «Astrapharm»</institution>
     <city>Moscow</city>
     <country>Russian Federation</country>
    </aff>
   </aff-alternatives>
   <aff-alternatives id="aff-8">
    <aff>
     <institution xml:lang="ru">ООО «БиоФерон»</institution>
     <city>Москва</city>
     <country>Россия</country>
    </aff>
    <aff>
     <institution xml:lang="en">LLC «BioFeron»</institution>
     <city>Moscow</city>
     <country>Russian Federation</country>
    </aff>
   </aff-alternatives>
   <aff-alternatives id="aff-9">
    <aff>
     <institution xml:lang="ru">ООО «НВП «Астрафарм»</institution>
     <city>Москва</city>
     <country>Россия</country>
    </aff>
    <aff>
     <institution xml:lang="en">LLC «RDE «Astrapharm»</institution>
     <city>Moscow</city>
     <country>Russian Federation</country>
    </aff>
   </aff-alternatives>
   <aff-alternatives id="aff-10">
    <aff>
     <institution xml:lang="ru">ООО «НПК «СКиФФ»</institution>
     <city>Москва</city>
     <country>Россия</country>
    </aff>
    <aff>
     <institution xml:lang="en">LLC «NPC «SKiFF»</institution>
     <city>Moscow</city>
     <country>Russian Federation</country>
    </aff>
   </aff-alternatives>
   <aff-alternatives id="aff-11">
    <aff>
     <institution xml:lang="ru">ООО «НВП «Астрафарм»</institution>
     <city>Москва</city>
     <country>Россия</country>
    </aff>
    <aff>
     <institution xml:lang="en">LLC «RDE «Astrapharm»</institution>
     <city>Moscow</city>
     <country>Russian Federation</country>
    </aff>
   </aff-alternatives>
   <aff-alternatives id="aff-12">
    <aff>
     <institution xml:lang="ru">ООО «БиоФерон»</institution>
     <city>Москва</city>
     <country>Россия</country>
    </aff>
    <aff>
     <institution xml:lang="en">LLC «BioFeron»</institution>
     <city>Moscow</city>
     <country>Russian Federation</country>
    </aff>
   </aff-alternatives>
   <pub-date publication-format="print" date-type="pub" iso-8601-date="2025-05-19T19:00:51+03:00">
    <day>19</day>
    <month>05</month>
    <year>2025</year>
   </pub-date>
   <pub-date publication-format="electronic" date-type="pub" iso-8601-date="2025-05-19T19:00:51+03:00">
    <day>19</day>
    <month>05</month>
    <year>2025</year>
   </pub-date>
   <volume>2025</volume>
   <issue>2</issue>
   <fpage>35</fpage>
   <lpage>44</lpage>
   <history>
    <date date-type="received" iso-8601-date="2025-05-09T00:00:00+03:00">
     <day>09</day>
     <month>05</month>
     <year>2025</year>
    </date>
   </history>
   <self-uri xlink:href="https://logospress.editorum.ru/en/nauka/article/98606/view">https://logospress.editorum.ru/en/nauka/article/98606/view</self-uri>
   <abstract xml:lang="ru">
    <p>В ходе токсикологической оценки установлено, что абсолютная (LD100) и средняя (LD50) летальные дозы ЛП Тразапентин® таблетки для кошек не определены и препарат в соответствии с ГОСТ 12.1.007-76 «Вредные вещества. Классификация и общие требования безопасности» был отнесен к IV классу опасности «Вещества малоопасные».&#13;
Исследование хронической токсичности ЛП Тразапентин® таблетки для кошек при его ежедневном пероральном введении крысам в течение 90 дней во всех исследуемых дозах показало отсутствие гибели животных и негативного воздействия на организм животных, как в период введения, так и после отмены.&#13;
ЛП Тразапентин® таблетки для кошек не обладает аллергизирующими и раздражающими свойствами в провокационной кожной и конъюнктивальной пробе.</p>
   </abstract>
   <trans-abstract xml:lang="en">
    <p>During toxicological assessment, it was established that the absolute (LD100) and median (LD50) lethal doses of the medicinal product Trazapentin® tablets for cats were not determined. According to GOST 12.1.007-76 «Harmful Substances. Classification and General Safety Requirements», the drug was classified as Hazard Class IV «Slightly Hazardous Substances».&#13;
A study of chronic toxicity of Trazapentin® tablets for cats with its daily oral administration to rats for 90 days at all tested doses showed no animal mortality and no negative impact on the animal body, both during administration and after discontinuation.&#13;
Trazapentin® tablets for cats do not possess allergenic or irritant properties in provocative skin and conjunctival tests.</p>
   </trans-abstract>
   <kwd-group xml:lang="ru">
    <kwd>Тразапентин®</kwd>
    <kwd>габапентин</kwd>
    <kwd>сукцинат тразодона</kwd>
    <kwd>тразодон</kwd>
    <kwd>острая токсичность</kwd>
    <kwd>хроническая токсичность</kwd>
    <kwd>аллергизирующие свойства</kwd>
   </kwd-group>
   <kwd-group xml:lang="en">
    <kwd>Trazapentine®</kwd>
    <kwd>succinate trazodone</kwd>
    <kwd>trazodone</kwd>
    <kwd>gabapentin</kwd>
    <kwd>acute toxicity</kwd>
    <kwd>chronic toxicity</kwd>
    <kwd>allergenic properties</kwd>
   </kwd-group>
  </article-meta>
 </front>
 <body>
  <p></p>
 </body>
 <back>
  <ref-list>
   <ref id="B1">
    <label>1.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Белоглазов, Д.В. Оценка эффективности нового препарата Экспресс Успокоин® таблетки при ситуационной коррекции поведенческих проблем у кошек / Д.В. Белоглазов, С.В. Мукасеев, О.А. Зейналов // Российский ветеринарный журнал. – 2023. – № 2. – С. 14-22. – DOI 10.32416/2500-4379-2023-2-14-22.</mixed-citation>
     <mixed-citation xml:lang="en">Beloglazov, D.V. Ocenka effektivnosti novogo preparata Ekspress Uspokoin® tabletki pri situacionnoy korrekcii povedencheskih problem u koshek / D.V. Beloglazov, S.V. Mukaseev, O.A. Zeynalov // Rossiyskiy veterinarnyy zhurnal. – 2023. – № 2. – S. 14-22. – DOI 10.32416/2500-4379-2023-2-14-22.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B2">
    <label>2.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Белоглазов, Д.В. Оценка эффективности нового препарата «Экспресс Успокоин® таблетки» при ситуационной коррекции поведенческих проблем у собак / Д.В. Белоглазов, С.В. Мукасеев, О.А. Зейналов // Современная ветеринарная медицина. – 2023. ‒ № 1. ‒ C. 18-22.</mixed-citation>
     <mixed-citation xml:lang="en">Beloglazov, D.V. Ocenka effektivnosti novogo preparata «Ekspress Uspokoin® tabletki» pri situacionnoy korrekcii povedencheskih problem u sobak / D.V. Beloglazov, S.V. Mukaseev, O.A. Zeynalov // Sovremennaya veterinarnaya medicina. – 2023. ‒ № 1. ‒ C. 18-22.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B3">
    <label>3.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Елизарова, Е.А. Оценка эффективности нового лекарственного препарата Курс Успокоин таблетки для коррекции возрастных когнитивных нарушений у кошек / Е.А. Елизарова, Д.В. Белоглазов, С.В. Мукасеев, О.А. Зейналов // Российский ветеринарный журнал. – 2024. – № 3. – С. 27-33. – DOI 10.32416/2500-4379-2024-3-27-33.</mixed-citation>
     <mixed-citation xml:lang="en">Elizarova, E.A. Ocenka effektivnosti novogo lekarstvennogo preparata Kurs Uspokoin tabletki dlya korrekcii vozrastnyh kognitivnyh narusheniy u koshek / E.A. Elizarova, D.V. Beloglazov, S.V. Mukaseev, O.A. Zeynalov // Rossiyskiy veterinarnyy zhurnal. – 2024. – № 3. – S. 27-33. – DOI 10.32416/2500-4379-2024-3-27-33.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B4">
    <label>4.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Белоглазов, Д.В. Тразодона сукцинат ‒ новые возможности фармакологической коррекции ситуационных поведенческих отклонений у собак и кошек / Д.В. Белоглазов, С.В. Мукасеев, О.А. Зейналов // Российский ветеринарный журнал. – 2021. – № 4. – С. 5-13. – DOI 10.32416/2500-4379-2021-4-5-13.</mixed-citation>
     <mixed-citation xml:lang="en">Beloglazov, D.V. Trazodona sukcinat ‒ novye vozmozhnosti farmakologicheskoy korrekcii situacionnyh povedencheskih otkloneniy u sobak i koshek / D.V. Beloglazov, S.V. Mukaseev, O.A. Zeynalov // Rossiyskiy veterinarnyy zhurnal. – 2021. – № 4. – S. 5-13. – DOI 10.32416/2500-4379-2021-4-5-13.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B5">
    <label>5.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Курс Успокоин таблетки. Инструкция по ветеринарному применению лекарственного препарата [Электронный ресурс]. https://galen.vetrf.ru/files/5c1ac33d-9461-4add-bd1c-e04b2d82f1fb (дата обращения 21.01.25).</mixed-citation>
     <mixed-citation xml:lang="en">Kurs Uspokoin tabletki. Instrukciya po veterinarnomu primeneniyu lekarstvennogo preparata [Elektronnyy resurs]. https://galen.vetrf.ru/files/5c1ac33d-9461-4add-bd1c-e04b2d82f1fb (data obrascheniya 21.01.25).</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B6">
    <label>6.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Приказ Министерства сельского хозяйства РФ №101 от 06.03.2018 г. «Об утверждении Правил проведения доклинического исследования лекарственного средства для ветеринарного применения, клинического исследования лекарственного препарата для ветеринарного применения, исследования биоэквивалентности лекарственного препарата для ветеринарного применения». Зарегистрирован в Минюсте России 05.06.2018 № 51296.</mixed-citation>
     <mixed-citation xml:lang="en">Prikaz Ministerstva sel'skogo hozyaystva RF №101 ot 06.03.2018 g. «Ob utverzhdenii Pravil provedeniya doklinicheskogo issledovaniya lekarstvennogo sredstva dlya veterinarnogo primeneniya, klinicheskogo issledovaniya lekarstvennogo preparata dlya veterinarnogo primeneniya, issledovaniya bioekvivalentnosti lekarstvennogo preparata dlya veterinarnogo primeneniya». Zaregistrirovan v Minyuste Rossii 05.06.2018 № 51296.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B7">
    <label>7.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Руководство по проведению доклинических исследований лекарственных средств. Часть первая / А.Н. Миронов, Н.Д. Бунатян и др. – М.: Гриф и К, 2012. – 944 с.</mixed-citation>
     <mixed-citation xml:lang="en">Rukovodstvo po provedeniyu doklinicheskih issledovaniy lekarstvennyh sredstv. Chast' pervaya / A.N. Mironov, N.D. Bunatyan i dr. – M.: Grif i K, 2012. – 944 s.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B8">
    <label>8.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Руководство по экспериментальному (доклиническому) изучению новых фармакологических веществ / Под ред. Р. У. Хабриева. – М.: Медицина, 2005. – 832с.</mixed-citation>
     <mixed-citation xml:lang="en">Rukovodstvo po eksperimental'nomu (doklinicheskomu) izucheniyu novyh farmakologicheskih veschestv / Pod red. R. U. Habrieva. – M.: Medicina, 2005. – 832s.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B9">
    <label>9.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Смирнов, А.В. Янтарная кислота и ее применение в медицине. Часть I. Янтарная кислота: метаболит и регулятор метаболизма организма человека / А.В. Смирнов, О.Б. Нестерова, Р.В. Голубев // Нефрология. – 2014. – Т. 18. – № 2. – С. 33-41.</mixed-citation>
     <mixed-citation xml:lang="en">Smirnov, A.V. Yantarnaya kislota i ee primenenie v medicine. Chast' I. Yantarnaya kislota: metabolit i regulyator metabolizma organizma cheloveka / A.V. Smirnov, O.B. Nesterova, R.V. Golubev // Nefrologiya. – 2014. – T. 18. – № 2. – S. 33-41.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B10">
    <label>10.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Экспресс Успокоин® таблетки. Инструкция по ветеринарному применению лекарственного препарата [Электронный ресурс]. https://galen.vetrf.ru/files/41fc97ef-69b3-4502-bded-57bb87220cd6 (дата обращения 21.01.25).</mixed-citation>
     <mixed-citation xml:lang="en">Ekspress Uspokoin® tabletki. Instrukciya po veterinarnomu primeneniyu lekarstvennogo preparata [Elektronnyy resurs]. https://galen.vetrf.ru/files/41fc97ef-69b3-4502-bded-57bb87220cd6 (data obrascheniya 21.01.25).</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B11">
    <label>11.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Adrian, D.E. Prescribing practices of veterinarians in the treatment of chronic musculoskeletal pain in cats / D.E. Adrian, M. Rishniw, M. Scherk, et al. // J Feline Med Surg. ‒ 2019 Jun. ‒ No. 21 (6). ‒ hh. 495-506. doi: 10.1177/1098612X18787910.</mixed-citation>
     <mixed-citation xml:lang="en">Adrian, D.E. Prescribing practices of veterinarians in the treatment of chronic musculoskeletal pain in cats / D.E. Adrian, M. Rishniw, M. Scherk, et al. // J Feline Med Surg. ‒ 2019 Jun. ‒ No. 21 (6). ‒ hh. 495-506. doi: 10.1177/1098612X18787910.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B12">
    <label>12.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Boyle, Y. The effect of a combination of gabapentin and donepezil in an experimental pain model in healthy volunteers: Results of a randomized controlled trial / Y. Boyle, D. Fernando, H. Kurz, S.R. Miller, M. Zucchetto, J. Storey // Pain. ‒ 2014. ‒ No. 155(12). ‒ pp. 2510-2516. doi:10.1016/j.pain.2014.09.003.</mixed-citation>
     <mixed-citation xml:lang="en">Boyle, Y. The effect of a combination of gabapentin and donepezil in an experimental pain model in healthy volunteers: Results of a randomized controlled trial / Y. Boyle, D. Fernando, H. Kurz, S.R. Miller, M. Zucchetto, J. Storey // Pain. ‒ 2014. ‒ No. 155(12). ‒ pp. 2510-2516. doi:10.1016/j.pain.2014.09.003.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B13">
    <label>13.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Cheng, H.F. Renal effects of non-steroidal anti-inflammatory drugs and selective cyclooxygenase-2 inhibitors / H.F. Cheng, R.C. Harris // Curr Pharm Des. ‒ 2005. ‒ No. 11(14). ‒ pp. 1795-1804. doi:10.2174/1381612053764922.</mixed-citation>
     <mixed-citation xml:lang="en">Cheng, H.F. Renal effects of non-steroidal anti-inflammatory drugs and selective cyclooxygenase-2 inhibitors / H.F. Cheng, R.C. Harris // Curr Pharm Des. ‒ 2005. ‒ No. 11(14). ‒ pp. 1795-1804. doi:10.2174/1381612053764922.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B14">
    <label>14.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Chincholkar, M. Analgesic mechanisms of gabapentinoids and effects in experimental pain models: a narrative review / M. Chincholkar // Br J Anaesth. ‒ 2018. ‒ No. 120(6). ‒ pp. 1315-1334. doi:10.1016/j.bja.2018.02.066.</mixed-citation>
     <mixed-citation xml:lang="en">Chincholkar, M. Analgesic mechanisms of gabapentinoids and effects in experimental pain models: a narrative review / M. Chincholkar // Br J Anaesth. ‒ 2018. ‒ No. 120(6). ‒ pp. 1315-1334. doi:10.1016/j.bja.2018.02.066.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B15">
    <label>15.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Edwards, R.R. Variability in conditioned pain modulation predicts response to NSAID treatment in patients with knee osteoarthritis / R.R. Edwards, A.J. Dolman, M.O. Martel, et al. // BMC Musculoskelet Disord. ‒ 2016. ‒ No. 17. ‒ pp. 284. Published 2016 Jul 13. doi:10.1186/s12891-016-1124-6.</mixed-citation>
     <mixed-citation xml:lang="en">Edwards, R.R. Variability in conditioned pain modulation predicts response to NSAID treatment in patients with knee osteoarthritis / R.R. Edwards, A.J. Dolman, M.O. Martel, et al. // BMC Musculoskelet Disord. ‒ 2016. ‒ No. 17. ‒ pp. 284. Published 2016 Jul 13. doi:10.1186/s12891-016-1124-6.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B16">
    <label>16.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Enomoto M., Anti-nerve growth factor monoclonal antibodies for the control of pain in dogs and cats / M. Enomoto, P.W. Mantyh, J. Murrell, J.F. Innes, B.D.X. Lascelles // Vet Rec. ‒ 2019. ‒ No. 184(1). ‒ pp. 23. doi:10.1136/vr.104590.</mixed-citation>
     <mixed-citation xml:lang="en">Enomoto M., Anti-nerve growth factor monoclonal antibodies for the control of pain in dogs and cats / M. Enomoto, P.W. Mantyh, J. Murrell, J.F. Innes, B.D.X. Lascelles // Vet Rec. ‒ 2019. ‒ No. 184(1). ‒ pp. 23. doi:10.1136/vr.104590.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B17">
    <label>17.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Garrone, B. Synergistic interaction between trazodone and gabapentin in rodent models of neuropathic pain / B. Garrone // PLoS One. ‒ 2021. ‒ No. 16(1). ‒ e0244649.</mixed-citation>
     <mixed-citation xml:lang="en">Garrone, B. Synergistic interaction between trazodone and gabapentin in rodent models of neuropathic pain / B. Garrone // PLoS One. ‒ 2021. ‒ No. 16(1). ‒ e0244649.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B18">
    <label>18.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Garry, E.M. Varicella zoster virus induces neuropathic changes in rat dorsal root ganglia and behavioral reflex sensitisation that is attenuated by gabapentin or sodium channel blocking drugs / E.M. Garry, A. Delaney, H.A. Anderson, et al. // Pain. ‒ 2005. ‒ No. 118 (1-2). ‒ pp. 97-111. doi:10.1016/j.pain.2005.08.003.</mixed-citation>
     <mixed-citation xml:lang="en">Garry, E.M. Varicella zoster virus induces neuropathic changes in rat dorsal root ganglia and behavioral reflex sensitisation that is attenuated by gabapentin or sodium channel blocking drugs / E.M. Garry, A. Delaney, H.A. Anderson, et al. // Pain. ‒ 2005. ‒ No. 118 (1-2). ‒ pp. 97-111. doi:10.1016/j.pain.2005.08.003.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B19">
    <label>19.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Gilron, I. Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial / J.M. Bailey, D. Tu, R.R. Holden, A.C. Jackson, R.L. Houlden // Lancet. ‒ 2009. ‒ No. 374(9697). ‒ pp. 1252-1261. doi:10.1016/S0140-6736(09)61081-3.</mixed-citation>
     <mixed-citation xml:lang="en">Gilron, I. Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial / J.M. Bailey, D. Tu, R.R. Holden, A.C. Jackson, R.L. Houlden // Lancet. ‒ 2009. ‒ No. 374(9697). ‒ pp. 1252-1261. doi:10.1016/S0140-6736(09)61081-3.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B20">
    <label>20.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Godfrey, D.R. Osteoarthritis in cats: a retrospective radiological study / D.R. Godfrey // J Small Anim Pract. ‒ 2005. ‒ No. 46(9). ‒ pp. 425-429. doi:10.1111/j.1748-5827.2005.tb00340.x</mixed-citation>
     <mixed-citation xml:lang="en">Godfrey, D.R. Osteoarthritis in cats: a retrospective radiological study / D.R. Godfrey // J Small Anim Pract. ‒ 2005. ‒ No. 46(9). ‒ pp. 425-429. doi:10.1111/j.1748-5827.2005.tb00340.x</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B21">
    <label>21.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Gruen, M.E. Detection of clinically relevant pain relief in cats with degenerative joint disease associated pain / M.E. Gruen, E. Griffith, A. Thomson, et al. // J Vet Intern Med. ‒ 2014. ‒No. 28(2). ‒ pp. 346-350.</mixed-citation>
     <mixed-citation xml:lang="en">Gruen, M.E. Detection of clinically relevant pain relief in cats with degenerative joint disease associated pain / M.E. Gruen, E. Griffith, A. Thomson, et al. // J Vet Intern Med. ‒ 2014. ‒No. 28(2). ‒ pp. 346-350.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B22">
    <label>22.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Gruen, M.E. AAHA Pain Management Guidelines for Dogs and Cats. / M.E. Gruen, B.D.X. Lascelles, E. Colleran, et al. // J Am Anim Hosp Assoc. ‒ 2022. ‒ No. 58(2). ‒ pp. 55-76. doi:10.5326/JAAHA-MS-7292.</mixed-citation>
     <mixed-citation xml:lang="en">Gruen, M.E. AAHA Pain Management Guidelines for Dogs and Cats. / M.E. Gruen, B.D.X. Lascelles, E. Colleran, et al. // J Am Anim Hosp Assoc. ‒ 2022. ‒ No. 58(2). ‒ pp. 55-76. doi:10.5326/JAAHA-MS-7292.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B23">
    <label>23.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Gruen, M.E. A Feline-Specific Anti-Nerve Growth Factor Antibody Improves Mobility in Cats with Degenerative Joint Disease-Associated Pain: A Pilot Proof of Concept Study. / M.E. Gruen, A.E. Thomson, E.H. Griffith, H. Paradise, D.P. Gearing, // J Vet Intern Med. ‒ 2016. ‒ No. 30(4). ‒ pp. 1138-1148. doi:10.1111/jvim.13972.</mixed-citation>
     <mixed-citation xml:lang="en">Gruen, M.E. A Feline-Specific Anti-Nerve Growth Factor Antibody Improves Mobility in Cats with Degenerative Joint Disease-Associated Pain: A Pilot Proof of Concept Study. / M.E. Gruen, A.E. Thomson, E.H. Griffith, H. Paradise, D.P. Gearing, // J Vet Intern Med. ‒ 2016. ‒ No. 30(4). ‒ pp. 1138-1148. doi:10.1111/jvim.13972.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B24">
    <label>24.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Guedes, A.G.P. Assessment of the effects of gabapentin on activity levels and owner-perceived mobility impirment and quality of life in osteoarthritic geriatric cats / A.G.P. Guedes, J.M. Meadows, B.H. Pypendop, et al. // J Am Vet Med Assoc. ‒ 2018. ‒ No. 253(5). ‒ pp. 579-85.</mixed-citation>
     <mixed-citation xml:lang="en">Guedes, A.G.P. Assessment of the effects of gabapentin on activity levels and owner-perceived mobility impirment and quality of life in osteoarthritic geriatric cats / A.G.P. Guedes, J.M. Meadows, B.H. Pypendop, et al. // J Am Vet Med Assoc. ‒ 2018. ‒ No. 253(5). ‒ pp. 579-85.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B25">
    <label>25.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Hardie, E.M. Radiographic evidence of degenerative joint disease in geriatric cats: 100 cases (1994-1997) / E.M. Hardie, S.C. Roe, F.R. Martin // J Am Vet Med Assoc. ‒ 2002. ‒ No. 220(5). ‒ pp. 628-632. doi:10.2460/javma.2002.220.628</mixed-citation>
     <mixed-citation xml:lang="en">Hardie, E.M. Radiographic evidence of degenerative joint disease in geriatric cats: 100 cases (1994-1997) / E.M. Hardie, S.C. Roe, F.R. Martin // J Am Vet Med Assoc. ‒ 2002. ‒ No. 220(5). ‒ pp. 628-632. doi:10.2460/javma.2002.220.628</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B26">
    <label>26.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Heughan, C.E. The interaction between gabapentin and amitriptyline in the rat formalin test after systemic administration / C.E. Heughan, J. Sawynok // Anesth Analg. ‒ 2002. ‒ No. 94(4). ‒ pp. 975-980. doi:10.1097/00000539-200204000-00037.</mixed-citation>
     <mixed-citation xml:lang="en">Heughan, C.E. The interaction between gabapentin and amitriptyline in the rat formalin test after systemic administration / C.E. Heughan, J. Sawynok // Anesth Analg. ‒ 2002. ‒ No. 94(4). ‒ pp. 975-980. doi:10.1097/00000539-200204000-00037.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B27">
    <label>27.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Liu, V.W.C. Antidepressants for the Treatment of Neuropathic Pain / V.W.C. Liu, L.W. Lam, H.F.K. Chiu // Hong Kong J Psychiatry. ‒ 2002. ‒ No. 12(4). ‒ pp. 23-27.</mixed-citation>
     <mixed-citation xml:lang="en">Liu, V.W.C. Antidepressants for the Treatment of Neuropathic Pain / V.W.C. Liu, L.W. Lam, H.F.K. Chiu // Hong Kong J Psychiatry. ‒ 2002. ‒ No. 12(4). ‒ pp. 23-27.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B28">
    <label>28.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Lascelles B.D.X. Management of chronic cancer pain / B.D.X. Lascelles. In: Withrow S, Vail D, Page R. (eds). Small animal clinical oncology. St Louis, MO: Elsevier, 2013, pp 245-259.</mixed-citation>
     <mixed-citation xml:lang="en">Lascelles B.D.X. Management of chronic cancer pain / B.D.X. Lascelles. In: Withrow S, Vail D, Page R. (eds). Small animal clinical oncology. St Louis, MO: Elsevier, 2013, pp 245-259.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B29">
    <label>29.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Martell-Moran, N.K. Pain and adverse behavior in declawed cats / N.K. Martell-Moran, M. Solano, H.G. Townsend // J Feline Med Surg. ‒ 2018. ‒ No. 20(4). ‒ pp. 280-288. doi:10.1177/1098612X1770504.</mixed-citation>
     <mixed-citation xml:lang="en">Martell-Moran, N.K. Pain and adverse behavior in declawed cats / N.K. Martell-Moran, M. Solano, H.G. Townsend // J Feline Med Surg. ‒ 2018. ‒ No. 20(4). ‒ pp. 280-288. doi:10.1177/1098612X1770504.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B30">
    <label>30.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Mizisin, A.P. Neurological complications associated with spontaneously occurring feline diabetes mellitus / A.P. Mizisin, G.D. Shelton, M.L. Burgers, H.C. Powell, P.A. Cuddon // J Neuropathol Exp Neurol. ‒ 2002. ‒ No. 61(10). ‒ pp. 872-884. doi:10.1093/jnen/61.10.872.</mixed-citation>
     <mixed-citation xml:lang="en">Mizisin, A.P. Neurological complications associated with spontaneously occurring feline diabetes mellitus / A.P. Mizisin, G.D. Shelton, M.L. Burgers, H.C. Powell, P.A. Cuddon // J Neuropathol Exp Neurol. ‒ 2002. ‒ No. 61(10). ‒ pp. 872-884. doi:10.1093/jnen/61.10.872.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B31">
    <label>31.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Monteiro, B.P. Chronic pain in cats: Recent advances in clinical assessment / B.P. Monteiro, P.V. Steagall // J Feline Med Surg. ‒ 2019. ‒ No. 21(7). ‒ pp. 601-614. doi:10.1177/1098612X19856179</mixed-citation>
     <mixed-citation xml:lang="en">Monteiro, B.P. Chronic pain in cats: Recent advances in clinical assessment / B.P. Monteiro, P.V. Steagall // J Feline Med Surg. ‒ 2019. ‒ No. 21(7). ‒ pp. 601-614. doi:10.1177/1098612X19856179</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B32">
    <label>32.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Muthuraman, A. Drug therapy of neuropathic pain: current developments and future perspectives / A. Muthuraman, N. Singh, A.S. Jaggi, M. Ramesh // Curr Drug Targets. ‒ 2014. ‒ No. 15(2). ‒ pp. 210-253.</mixed-citation>
     <mixed-citation xml:lang="en">Muthuraman, A. Drug therapy of neuropathic pain: current developments and future perspectives / A. Muthuraman, N. Singh, A.S. Jaggi, M. Ramesh // Curr Drug Targets. ‒ 2014. ‒ No. 15(2). ‒ pp. 210-253.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B33">
    <label>33.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Oggianu, L. PK/PD analysis of trazodone and gabapentin in neuropathic pain rodent models: Translational PK-PD modeling from nonclinical to clinical development / L. Oggianu, B. Garrone, F. Fiorentini, et al. // Clin Transl Sci. ‒ 2023. ‒ No. 16(4). ‒ pp. 606-617. doi:10.1111/cts.13472.</mixed-citation>
     <mixed-citation xml:lang="en">Oggianu, L. PK/PD analysis of trazodone and gabapentin in neuropathic pain rodent models: Translational PK-PD modeling from nonclinical to clinical development / L. Oggianu, B. Garrone, F. Fiorentini, et al. // Clin Transl Sci. ‒ 2023. ‒ No. 16(4). ‒ pp. 606-617. doi:10.1111/cts.13472.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B34">
    <label>34.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Okuda, K. Trazodone hydrochloride attenuates thermal hyperalgesia in a chronic constriction injury rat model / K. Okuda, T. Takanishi, K. Yoshimoto, S. Ueda // Eur J Anaesthesiol. ‒ 2003. ‒ No. 20(5). ‒ pp. 409-415. doi:10.1017/s0265021503000632.</mixed-citation>
     <mixed-citation xml:lang="en">Okuda, K. Trazodone hydrochloride attenuates thermal hyperalgesia in a chronic constriction injury rat model / K. Okuda, T. Takanishi, K. Yoshimoto, S. Ueda // Eur J Anaesthesiol. ‒ 2003. ‒ No. 20(5). ‒ pp. 409-415. doi:10.1017/s0265021503000632.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B35">
    <label>35.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Patel, R. Mechanisms of the gabapentinoids and α 2 δ-1 calcium channel subunit in neuropathic pain / R. Patel, A.H. Dickenson // Pharmacol Res Perspect. ‒ 2016. ‒ No. 4(2). ‒ e00205. Published 2016 Feb 27. doi:10.1002/prp2.205.</mixed-citation>
     <mixed-citation xml:lang="en">Patel, R. Mechanisms of the gabapentinoids and α 2 δ-1 calcium channel subunit in neuropathic pain / R. Patel, A.H. Dickenson // Pharmacol Res Perspect. ‒ 2016. ‒ No. 4(2). ‒ e00205. Published 2016 Feb 27. doi:10.1002/prp2.205.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B36">
    <label>36.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Petrere, J.A. Developmental toxicity studies in mice, rats, and rabbits with the anticonvulsant gabapentin / J.A. Petrere, J.A. Anderson // Fundam Appl Toxicol. ‒ 1994. ‒ No. 23(4). ‒ pp. 585-589. doi:10.1006/faat.1994.1144.</mixed-citation>
     <mixed-citation xml:lang="en">Petrere, J.A. Developmental toxicity studies in mice, rats, and rabbits with the anticonvulsant gabapentin / J.A. Petrere, J.A. Anderson // Fundam Appl Toxicol. ‒ 1994. ‒ No. 23(4). ‒ pp. 585-589. doi:10.1006/faat.1994.1144.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B37">
    <label>37.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Slingerland, L.I. Cross-sectional study of the prevalence and clinical features of osteoarthritis in 100 cats / L.I. Slingerland, H.A. Hazewinkel, B.P. Meij, P. Picavet, G. Voorhout // Vet J. ‒ 2011. ‒ No. 187(3). ‒ pp. 304-309. doi:10.1016/j.tvjl.2009.12.014.</mixed-citation>
     <mixed-citation xml:lang="en">Slingerland, L.I. Cross-sectional study of the prevalence and clinical features of osteoarthritis in 100 cats / L.I. Slingerland, H.A. Hazewinkel, B.P. Meij, P. Picavet, G. Voorhout // Vet J. ‒ 2011. ‒ No. 187(3). ‒ pp. 304-309. doi:10.1016/j.tvjl.2009.12.014.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B38">
    <label>38.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Sparkes, A.H. ISFM consensus guidelines on the practical management of diabetes mellitus in cats / A.H. Sparkes, M. Cannon, D. Church, et al. // J Feline Med Surg. ‒ 2015. ‒ No. 17(3). ‒ pp. 235-250. doi:10.1177/1098612X15571880.</mixed-citation>
     <mixed-citation xml:lang="en">Sparkes, A.H. ISFM consensus guidelines on the practical management of diabetes mellitus in cats / A.H. Sparkes, M. Cannon, D. Church, et al. // J Feline Med Surg. ‒ 2015. ‒ No. 17(3). ‒ pp. 235-250. doi:10.1177/1098612X15571880.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B39">
    <label>39.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Stahl, S.M. Mechanism of action of trazodone: a multifunctional drug / S.M. Stahl // CNS Spectr. ‒ 2009. ‒ No. 14(10). ‒ pp. 536-546. doi:10.1017/s1092852900024020.</mixed-citation>
     <mixed-citation xml:lang="en">Stahl, S.M. Mechanism of action of trazodone: a multifunctional drug / S.M. Stahl // CNS Spectr. ‒ 2009. ‒ No. 14(10). ‒ pp. 536-546. doi:10.1017/s1092852900024020.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B40">
    <label>40.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Steagall, P.V. Multimodal analgesia for perioperative pain in three cats / P.V. Steagall, B.P. Monteiro-Steagall // J Feline Med Surg. ‒ 2013. ‒ No. 15(8). ‒ pp. 737-743. doi:10.1177/1098612X13476033.</mixed-citation>
     <mixed-citation xml:lang="en">Steagall, P.V. Multimodal analgesia for perioperative pain in three cats / P.V. Steagall, B.P. Monteiro-Steagall // J Feline Med Surg. ‒ 2013. ‒ No. 15(8). ‒ pp. 737-743. doi:10.1177/1098612X13476033.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B41">
    <label>41.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Taylor, C.P. Mechanisms of action of gabapentin / C.P. Taylor // Rev Neurol (Paris). ‒ 1997. ‒ No. 153 Suppl 1. ‒ S39-S45.</mixed-citation>
     <mixed-citation xml:lang="en">Taylor, C.P. Mechanisms of action of gabapentin / C.P. Taylor // Rev Neurol (Paris). ‒ 1997. ‒ No. 153 Suppl 1. ‒ S39-S45.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B42">
    <label>42.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Vasudevan, R. Alleviation of neuropathic pain by trazodone in rats / R. Vasudevan // Brazilian Journal of Pharmaceutical Sciences. ‒ 2022. ‒ No. 58. ‒ e19256.</mixed-citation>
     <mixed-citation xml:lang="en">Vasudevan, R. Alleviation of neuropathic pain by trazodone in rats / R. Vasudevan // Brazilian Journal of Pharmaceutical Sciences. ‒ 2022. ‒ No. 58. ‒ e19256.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B43">
    <label>43.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Walsh, K. Chronic pain management in dogs and cats / K. Walsh // In Pract. ‒ 2016. ‒ No. 38. ‒ pp. 155-65. doi: 10.1136/inp.i1489</mixed-citation>
     <mixed-citation xml:lang="en">Walsh, K. Chronic pain management in dogs and cats / K. Walsh // In Pract. ‒ 2016. ‒ No. 38. ‒ pp. 155-65. doi: 10.1136/inp.i1489</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B44">
    <label>44.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Watanabe, R. A multidisciplinary study of pain in cats undergoing dental extractions: A prospective, blinded, clinical trial / R. Watanabe, G. Doodnaught, C. Proulx, et al. // PLoS One. ‒ 2019. ‒ No. 14(3). ‒ e0213195. Published 2019 Mar 1. doi:10.1371/journal.pone.0213195.</mixed-citation>
     <mixed-citation xml:lang="en">Watanabe, R. A multidisciplinary study of pain in cats undergoing dental extractions: A prospective, blinded, clinical trial / R. Watanabe, G. Doodnaught, C. Proulx, et al. // PLoS One. ‒ 2019. ‒ No. 14(3). ‒ e0213195. Published 2019 Mar 1. doi:10.1371/journal.pone.0213195.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B45">
    <label>45.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Watanabe, R. Pain behaviors before and after treatment of oral disease: preliminary results / R. Watanabe, D. Frank, P. Steagall. In: Proceeding of 8th Annual Congress of Asian Society of Veterinary Surgery. Taichung, Taiwan, 2018. pp.1-11.</mixed-citation>
     <mixed-citation xml:lang="en">Watanabe, R. Pain behaviors before and after treatment of oral disease: preliminary results / R. Watanabe, D. Frank, P. Steagall. In: Proceeding of 8th Annual Congress of Asian Society of Veterinary Surgery. Taichung, Taiwan, 2018. pp.1-11.</mixed-citation>
    </citation-alternatives>
   </ref>
  </ref-list>
 </back>
</article>
